Clinical trials
Recruiting Phase 1/2 Liposarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2021 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ascentage Pharma Group Inc. | 1 |
| Grupo Espanol de Investigacion en Sarcomas | 1 |
| Lamassu Bio Inc | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Milton S. Hershey Medical Center | 1 |
| National Cancer Institute (NCI) | 1 |
| STORM Therapeutics LTD | 1 |
| St. Jude Children's Research Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liposarcoma | 8 |
| Leiomyosarcoma | 4 |
| Sarcoma | 4 |
| Liposarcoma, Myxoid | 3 |
| Osteosarcoma | 2 |
| Dermatofibrosarcoma | 1 |
| Disorders of Sex Development | 1 |
| Fibrosarcoma | 1 |
| Glomus Tumor | 1 |
| Granular Cell Tumor | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.